Travere Drug Patent Portfolio
Travere owns 1 orange book drug protected by 1 US patent Given below is the list of Travere's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9993461 | Method for treating disorders associated with glomerular function | 29 Mar, 2030 | Active |
Latest Legal Activities on Travere's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Travere.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 08 May, 2024 | US9993461 |
| Letter from FDA or Dept of Agriculture re PTE application | 30 Jan, 2024 | US9993461 |
| Initial letter Re: PTE Application to regulating agency | 17 Nov, 2023 | US9993461 |
| Resp. to req. for info. sent under 37 CFR 1.750 | 12 Sep, 2023 | US9993461 |
| Requirement for information sent under 37 CFR 1.750 | 04 Aug, 2023 | US9993461 |
| Patent Term Extension Application under 35 USC 156 Filed | 14 Apr, 2023 | US9993461 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 13 Dec, 2021 | US9993461 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Jun, 2018 | US9993461 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Jun, 2018 | US9993461 |
|
Email Notification
Critical
| 24 May, 2018 | US9993461 |
|
Issue Notification Mailed
Critical
| 23 May, 2018 | US9993461 |
| Dispatch to FDC | 14 May, 2018 | US9993461 |
| Printer Rush- No mailing | 23 Apr, 2018 | US9993461 |
|
Pubs Case Remand to TC
Critical
| 16 Apr, 2018 | US9993461 |
| Printer Rush- No mailing | 04 Apr, 2018 | US9993461 |
Travere Drug Patents' Oppositions Filed in EPO
Travere drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Nov 23, 2020, by Pajaro Limited. This opposition was filed on patent number EP17157697A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP17157697A | Nov, 2020 | Pajaro Limited | Granted and Under Opposition |
Travere's Family Patents
Travere Drug List
Given below is the complete list of Travere's drugs and the patents protecting them.
1. Filspari
Filspari is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9993461 | Method for treating disorders associated with glomerular function |
29 Mar, 2030
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Filspari's drug page